1. PO-0665: Compliance with ILROG guidelines in the treatment of extranodal lymphomas; an internal plans review. (April 2016) Authors: Furlan, C.; Bulian, P.; Michieli, M.; Trovo, M.; Ermacora, A.; Spina, M.; Tirelli, U.; Franchin, F. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0666: Comparing the efficacy of low-dose radiotherapy in patients with aggressive and indolent lymphomas. (April 2016) Authors: Furlan, C.; Bulian, P.; Michieli, M.; Spina, M.; Ermacora, A.; Trovo, M.; Tirelli, U.; Franchin, G. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA. (23rd June 2022) Authors: Pirosa, M. C.; Bruscaggin, A.; Terzi di Bergamo, L.; Salehi, M.; Pini, K.; Spina, V.; Bocchetta, S.; Condoluci, A.; Forestieri, G.; Piffaretti, D.; Marques De Almeida, J.; Annunziata, S.; Bergesio, F.; Borsatti, E.; Bulian, P.; Chauvie, S.; Marco, C.; Martina, D. T.; Bernhard, G.; Kurlapski, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1246: Radiotherapy after autologous stem cell transplant in recurrent or refractory hodgkin's lymphoma. (April 2018) Authors: Matrone, F.; Furlan, C.; Rupolo, M.; Ciancia, R.; Zanet, E.; Montante, B.; Navarria, F.; Palazzari, E.; Farina, E.; Bulian, P.; Mascarin, M.; De Paoli, A.; Franchin, G.; Michieli, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NOTCH1 MUTATED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE CHARACTERIZED BY a MYC‐RELATED OVEREXPRESSION OF NUCLEOPHOSMIN‐1 AND RIBOSOME ASSOCIATED COMPONENTS. (June 2017) Authors: Pozzo, F.; Bittolo, T.; Vendramini, E.; Bomben, R.; Bulian, P.; Rossi, F.M.; Zucchetto, A.; Tissino, E.; Degan, M.; D'Arena, G.; Di Raimondo, F.; Zaja, F.; Pozzato, G.; Rossi, D.; Gaidano, G.; Del Poeta, G.; Gattei, V.; Dal Bo, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗